The Therapeutic Potential of Inhibitors of Dipeptidyl Peptidase IV (DPP IV) and Related Proline-Specific Dipeptidyl Aminopeptidases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|8|971-998

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.8, 2005-04, pp. : 971-998

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes

By Augustyns Koen   Van der Veken Pieter   Haemers Achiel  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 10, 2005-10 ,pp. : 1387-1407

Informa Healthcare

Access to resources Recommend Favorite

Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV)

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 6, 2007-03 ,pp. : 597-608

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

By Drucker DJ  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 87-100

Informa Healthcare

Access to resources Recommend Favorite

Docking Study of Novel Pyrrolidine Derivatives as Potential Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 4, 2015-05 ,pp. : 284-291

Bentham Science Publishers

Access to resources Recommend Favorite

Prolyl Peptidases Related to Dipeptidyl Peptidase IV: Potential of Specific Inhibitors in Drug Discovery.

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 6, 2007-03 ,pp. : 621-635

Bentham Science Publishers

Access to resources Recommend Favorite